000 | 00852 a2200181 4500 | ||
---|---|---|---|
020 | _a0824750624 | ||
020 | _a9780824750626 | ||
082 | 0 | 4 |
_a615.19 _bCHI |
245 | 0 | 0 | _aChirality in drug design and development. |
250 | _a1st ed. | ||
260 |
_a[S.l.] : _bCRC Press, _c2004. |
||
300 | _a1200 p. ; | ||
500 | _aTextbook Binding. | ||
520 | _aCovering every essential element in the development of chiral products, this reference provides a solid overview of the formulation, biopharmaceutical characteristics, and regulatory issues impacting the production of these pharmaceuticals—supporting researchers as they critically evaluate the pharmacodynamic, pharmacokinetic, and toxicological characteristics of specific enantiomers and chiral drug compounds | ||
700 |
_aReddy, Indra K _9252390 |
||
700 |
_aMehvar, Reza _9252391 |
||
942 | _cBK | ||
999 |
_c54320 _d54320 |